Società | Nome | Borsa | Settore | Industria | Capitalizzazione di mercato | Rapporto Prezzo/Utile | Rapporto PEG | Ultimo prezzo di scambio | Variazione giornaliera (%) | Fair Value | Rialzo Fair Value | Etichetta Fair Value | Price Target (analisti) | Rialzo target analisti | Salute complessiva |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Ryvu | Varsavia | Salute | Ricerca medica e biotecnologica | 1,06 Mrd PLN | -10,4x | 0,28 | 45,40 PLN | -4,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Selvita | Varsavia | Salute | Ricerca medica e biotecnologica | 1,01 Mrd PLN | 22x | 0,45 | 51,30 PLN | -6,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 31,5% Rialzo | Fai l’upgrade a Pro+ | |
Scope Fluidics | Varsavia | Salute | Ricerca medica e biotecnologica | 438,87 Mln PLN | -16,6x | 0,16 | 162,80 PLN | -0,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 44,4% Rialzo | Fai l’upgrade a Pro+ | |
Captor Therapeutics | Varsavia | Salute | Ricerca medica e biotecnologica | 276,97 Mln PLN | -7,6x | -0,2 | 55,20 PLN | -7,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Bioton | Varsavia | Salute | Ricerca medica e biotecnologica | 272,19 Mln PLN | -47,1x | 0,15 | 3,20 PLN | 1,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Poltreg | Varsavia | Salute | Ricerca medica e biotecnologica | 228,51 Mln PLN | -15,6x | 0,02 | 48,60 PLN | -0,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 17,4% Rialzo | Fai l’upgrade a Pro+ | |
Mabion | Varsavia | Salute | Ricerca medica e biotecnologica | 176,17 Mln PLN | 17,2x | -0,23 | 10,90 PLN | -1,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | 33% Rialzo | Fai l’upgrade a Pro+ | |
Molecure | Varsavia | Salute | Ricerca medica e biotecnologica | 153,71 Mln PLN | -5x | -0,16 | 9,10 PLN | -5,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Urteste | Varsavia | Salute | Ricerca medica e biotecnologica | 124,33 Mln PLN | -29,7x | -0,95 | 89,20 PLN | 1,1% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Hyenergy | Varsavia | Salute | Ricerca medica e biotecnologica | 119,21 Mln PLN | -3,5x | 0,14 | 3,55 PLN | -4,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Genomtec | Varsavia | Salute | Ricerca medica e biotecnologica | 99,93 Mln PLN | -8,8x | -0,41 | 7,60 PLN | 1,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Sds Optic | Varsavia | Salute | Ricerca medica e biotecnologica | 76,41 Mln PLN | 12,04 PLN | -7,4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||||
Nanogroup | Varsavia | Salute | Ricerca medica e biotecnologica | 70,97 Mln PLN | -8,3x | 0,04 | 2,96 PLN | -1,3% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Pure Biologics | Varsavia | Salute | Ricerca medica e biotecnologica | 70,01 Mln PLN | -2,3x | -0,06 | 19 PLN | -0,7% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Readgene | Varsavia | Salute | Ricerca medica e biotecnologica | 61,31 Mln PLN | -60,9x | 5,24 PLN | 4% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
Genomed | Varsavia | Salute | Ricerca medica e biotecnologica | 35,94 Mln PLN | 61x | 0,52 | 27,20 PLN | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Medicofarma Biotech | Varsavia | Salute | Ricerca medica e biotecnologica | 25,49 Mln PLN | -9,4x | 0,25 | 0,38 PLN | -3,8% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Braster | Varsavia | Salute | Ricerca medica e biotecnologica | 17,04 Mln PLN | -4x | 0,58 PLN | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
Stem Cells Spin | Varsavia | Salute | Ricerca medica e biotecnologica | 11,08 Mln PLN | -29,8x | 0,12 | 0,27 PLN | 3,9% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Sygnis | Varsavia | Salute | Ricerca medica e biotecnologica | 9,09 Mln PLN | -3,6x | 0,36 PLN | -5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | |||
E Shopping | Varsavia | Salute | Ricerca medica e biotecnologica | 7,56 Mln PLN | -8,9x | 0,12 | 0,78 PLN | -3,5% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | ||
Private Rented Sector | Varsavia | Salute | Ricerca medica e biotecnologica | 4,07 Mln PLN | -60,4x | 3,27 | 3,08 PLN | 0% | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ | Fai l’upgrade a Pro+ |